Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(5-METHYL-1 H-BENZOIMIDAZOL-2-YL)-PHENYLAMINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

110178-74-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 110178-74-0 Structure
  • Basic information

    1. Product Name: 4-(5-METHYL-1 H-BENZOIMIDAZOL-2-YL)-PHENYLAMINE
    2. Synonyms: 4-(5-METHYL-1 H-BENZOIMIDAZOL-2-YL)-PHENYLAMINE;4-(5-methyl-1H-benzimidazol-2-yl)aniline;[4-(6-methyl-1H-benzimidazol-2-yl)phenyl]amine;4-(6-methyl-1H-benzimidazol-2-yl)aniline;4-(5-methyl-1H-benzo[d]imidazol-2-yl)aniline
    3. CAS NO:110178-74-0
    4. Molecular Formula: C14H13N3
    5. Molecular Weight: 223.27
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 110178-74-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 474.8°C at 760 mmHg
    3. Flash Point: 272.4°C
    4. Appearance: /
    5. Density: 1.247g/cm3
    6. Vapor Pressure: 3.5E-09mmHg at 25°C
    7. Refractive Index: 1.714
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 11.80±0.10(Predicted)
    11. CAS DataBase Reference: 4-(5-METHYL-1 H-BENZOIMIDAZOL-2-YL)-PHENYLAMINE(CAS DataBase Reference)
    12. NIST Chemistry Reference: 4-(5-METHYL-1 H-BENZOIMIDAZOL-2-YL)-PHENYLAMINE(110178-74-0)
    13. EPA Substance Registry System: 4-(5-METHYL-1 H-BENZOIMIDAZOL-2-YL)-PHENYLAMINE(110178-74-0)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 110178-74-0(Hazardous Substances Data)

110178-74-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 110178-74-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,1,7 and 8 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 110178-74:
(8*1)+(7*1)+(6*0)+(5*1)+(4*7)+(3*8)+(2*7)+(1*4)=90
90 % 10 = 0
So 110178-74-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H13N3/c1-9-2-7-12-13(8-9)17-14(16-12)10-3-5-11(15)6-4-10/h2-8H,15H2,1H3,(H,16,17)

110178-74-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(6-methyl-1H-benzimidazol-2-yl)aniline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:110178-74-0 SDS

110178-74-0Relevant articles and documents

Benzimidazole based mesogenic Schiff-bases: Synthesis and characterization

Dubey, Ragini,Yerrasani, Rajasekhar,Karunakar,Singh, Angad Kumar,Gupta, Rupali,Ganesan, Vellaichamy,Rao

, p. 106 - 114 (2017)

Two homologous series of mesogenic Schiff-bases, N-4-((alkoxy)-(phenyl-3-hydroxy-4-(4-(5-methylbenzimidazol))-2-alkoxysalicylaldimine)benzoate (7a–d) and N-4′-(5-methyl-benzimidazole)-phenyl-4-alkoxysalicylaldimine (8a–d) incorporating benzimidazole moiety have been prepared and the molecular structures studied by FT-IR, NMR and ESI-MS spectrometry. Mesogenic behaviour was investigated by polarizing optical microscopy (POM), differential scanning calorimetry (DSC) and variable temperature powder X-ray diffraction (PXRD) techniques. Changing the spacer (ester-linked to non-ester linked) of the Schiff-base results in enhancement of thermal stability and phase transition temperature. The members of series-I show monotropic SmA while those of series-II reflect enantiotropic SmA mesomorphism. An electrochemical study of a representative Schiff base in each series (7d and 8c) showed an electrical band gap 1.26?eV and 1.22?eV respectively.

1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl] -urea derivatives as small molecule heparanase inhibitors

Pan, Weitao,Miao, Hua-Quan,Xu, Yong-Jiang,Navarro, Elizabeth C.,Tonra, James R.,Corcoran, Erik,Lahiji, Armin,Kussie, Paul,Kiselyov, Alexander S.,Wong, Wai C.,Liu, Hu

, p. 409 - 412 (2007/10/03)

A novel class of 1-[4-(1H-benzoimidazol-2-yl)-phenyl]-3-[4-(1H- benzoimidazol-2-yl)-phenyl]-ureas are described as potent inhibitors of heparanase. Among them are 1,3-bis-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea (7a) and 1,3-bis-[4-(5,6-dimethyl-1H-benzoimidazol-2-yl)-phenyl]-urea (7d), which displayed good heparanase inhibitory activity (IC50 0.075-0.27 μM). Compound 7a showed good efficacy in a B16 metastasis model.

Benzimidazole compounds for regulating IgE

-

, (2008/06/13)

This invention relates to a family of phenylbenzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.

Benzimidazole derivatives as modulators of IgE

-

, (2008/06/13)

This invention relates to a family of benzimidazole analogs, which are inhibitors of the IgF response to allergens. These compounds are useful in the treatment of allergy, asthma, or any diseases where IgE is pathogenic.

Benzimidazole compounds for regulating IgE

-

, (2008/06/13)

This invention relates to a family of phenylbenzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.

Benzimidazole derivatives as modulators of IgE

-

, (2008/06/13)

This invention relates to a family of diacyl benzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 110178-74-0